Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

201986 citationsReviewgreen Open Access

Authors

Ben M. Eyck · Erasmus MC

Barbera D. Onstenk · Erasmus MC

Bo Jan Noordman · Erasmus MC

Daan Nieboer · Erasmus MC

Manon C.W. Spaander · Erasmus MC

Roelf Valkema · Erasmus MC

Sjoerd M. Lagarde · Erasmus MC

Abstract

Current literature suggests insufficient accuracy of endoscopic biopsies, EUS, and 18F-FDG PET(-CT) as single modalities for detecting residual disease after nCRT for esophageal cancer.

Topics & Keywords

Esophageal Cancer Research and Treatment Gastric Cancer Management and Outcomes Lung Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Surgery

Volume 271, Issue 2, pp. 245-256

DOI: 10.1097/sla.0000000000003397

Field-Weighted Citation Impact: 9.72